<DOC>
	<DOC>NCT02308839</DOC>
	<brief_summary>This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE速 Excluder速 Endoprosthesis in the treatment of infra-renal Abdominal Aortic Aneurysms (AAA).</brief_summary>
	<brief_title>GORE速 EXCLUDER速 Endprosthesis French Mandatory Registry</brief_title>
	<detailed_description>The use of abdominal aortic endoprostheses makes the treatment of infra-renal abdominal aortic aneurysms possible, with implantation via the femoral artery, thus avoiding a very invasive surgical procedure. The French National Authority for Health requires a 5-year follow-up as part of the renewal for reimbursement for these endprostheses.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<criteria>Any patients requiring abdominal aortic stenting for the treatment of an unruptured infrarenal aortic abdominal aneurysm. Patients whose clinical followup is not possible, i.eg, patient who cannot return for control visits (e.g. patients living abroad).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Aneurysm</keyword>
	<keyword>Aorta</keyword>
	<keyword>Abdominal</keyword>
</DOC>